Halozyme Therapeutics, Inc. technical analysis
Technical analysis of Halozyme Therapeutics, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. is a biopharmaceutical company that develops and commercializes proprietary enzymes and devices based on recombinant human hyaluronidase enzyme (rHuPH20) technology, which enables subcutaneous administration of biological drugs and therapeutic molecules. The company's product portfolio includes formulations for testosterone replacement therapy and subcutaneous versions of medications for treating oncological, immunological, and autoimmune diseases, developed through collaborations with international pharmaceutical partners.
Description generated automatically from public sources; it may be inaccurate or out of date.
Halozyme Therapeutics, Inc.: latest session data
Closing values for September 4, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
105.78 $
+4.17%
50 sessions
90.67 $
+21.53%
200 sessions
74.21 $
+48.48%
Session levels
s2
107.81
Support
s1
109.28
Support
pivot
110.22
Pivot
r1
111.69
Resistance
r2
112.63
Resistance
How to read it
In the September 4, 2026 session Halozyme Therapeutics, Inc. closed lower at 110.19 $, −0.51% versus the previous session.
The price sits above every moving average observed: +4.17% against the 21-session average, +21.53% against the 50 and +48.48% against the 200.
The 14-period RSI reads 72.4, in overbought territory.
MACD stands at 5.646 against a signal line at 6.153: the histogram is negative (−0.507).
ADX reads 47.5, indicating a marked directionality.
Levels computed on the latest session place supports at 109.28 and 107.81 $ and resistances at 111.69 and 112.63 $, around a pivot of 110.22.
The average daily range (ATR) is 2.851 $, or 2.59% of price.
Turnover was 1M shares, 51% of the 20-session average.
Over the last twelve months the price ranged between 61.33 and 111.15 $, and today stands −0.86% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the HALO analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Halozyme Therapeutics, Inc.
How is Halozyme Therapeutics, Inc. analysed technically?
Technical analysis of Halozyme Therapeutics, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Halozyme Therapeutics, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Halozyme Therapeutics, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Halozyme Therapeutics, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.